Immunovant, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Immunovant, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2024.
  • Immunovant, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 146M shares, a 11.9% increase year-over-year.
  • Immunovant, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 138M shares, a 12.2% increase from 2022.
  • Immunovant, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 123M shares, a 12.2% increase from 2021.
  • Immunovant, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 110M shares, a 25% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 146M +15.6M +11.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 138M +15M +12.2% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-29
Q4 2023 145M +15.9M +12.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 131M +14.6M +12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 131M +13.9M +12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 123M +13.4M +12.2% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-29
Q4 2022 129M +13.5M +11.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 117M +7.49M +6.87% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 117M +18.6M +19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 110M +21.9M +25% Jan 1, 2022 Mar 31, 2022 10-K 2023-05-22
Q4 2021 115M +17.1M +17.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-03
Q3 2021 109M +24.7M +29.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 98M +27.2M +38.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 87.8M Jan 1, 2021 Mar 31, 2021 10-K 2022-06-08
Q4 2020 97.9M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-04
Q3 2020 84.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 70.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.